Control of cyclic AMP levels in primary cultures of human tracheal smooth muscle cells
Open Access
- 1 October 1992
- journal article
- Published by Wiley in British Journal of Pharmacology
- Vol. 107 (2) , 422-428
- https://doi.org/10.1111/j.1476-5381.1992.tb12762.x
Abstract
1 [3H]-adenosine 3′:5′-cyclic monophosphate ([3H]-cyclic AMP) responses were studied in primary cultures of human tracheal smooth muscle cells derived from explants of human trachealis muscle and in short term cultures of acutely dissociated trachealis cells. 2 Isoprenaline induced concentration-dependent [3H]-cyclic AMP formation wtih an EC50 of 0.2 μm. The response to 10 μm isoprenaline reached a maximum after 5–10 min stimulation and remained stable for periods of up to 1 h. After 10 min stimulation, 1 μm isoprenaline produced a 9.5 fold increase over basal [3H]-cyclic AMP levels. The response to isoprenaline was inhibited by ICI 118551 (10 nm), (apparent KA 1.9 × 109 m−1) indicating the probable involvement of a β2-adrenoceptor in this response in human cultured tracheal smooth muscle cells. However, with 50 nm ICI 118551 there was a reduction in the maximum response to isoprenaline. Prostaglandin E2 also produced concentration-dependent [3H]-cyclic AMP formation (EC50 0.7 μm, response to 1 μm PGE2 6.4 fold over basal). 3 Forskolin (1 nm-100 μm) induced concentration-dependent [3H]-cyclic AMP formation in these cells. A 1.6 fold (over basal) response was also observed following stimulation with NaF (10 mm). 4 The nonselective phosphodiesterase inhibitor 3-isobutyl-1-methylxanthine (IBMX) (0.1 mm) and the type IV, cyclic AMP selective, phosphodiesterase inhibitor rolipram (0.1 mm) both elevated basal [3H]-cyclic AMP levels by 1.8 and 1.5 fold respectively. IBMX (1–100 μm) and low concentrations of rolipram (< 10 μm), also potentiated the response to 1 μm isoprenaline. Inhibitors of the type III phosphodiesterase isoenzyme (SK&F 94120 and SK&F 94836) were without effect upon basal or isoprenaline-stimulated cyclic AMP responses in these cells. 5 Carbachol (1 nm-100 μm) produced concentration-dependent inhibition of the [3H]-cyclic AMP response to 1 μm isoprenaline in human cultured tracheal smooth muscle cells (IC50 0.24 μm). Carbachol (1 μm) inhibited the [3H]-cyclic AMP response to 1 μm isoprenaline by 60%. This effect of carbachol was itself inhibited by atropine (50 nm) (KA 2.3 × 109 m−1) indicating the involvement of a muscarinic receptor. 6 These results show that primary cultures of human tracheal smooth muscle cells demonstrate cyclic AMP responses to direct receptor stimulation, adenylyl cyclase activation and inhibition with nonselective and type IV-selective cyclic AMP phosphodiesterase isoenzyme inhibitors, and that the cyclic AMP response to isoprenaline can be inhibited by muscarinic receptor stimulation.Keywords
This publication has 31 references indexed in Scilit:
- Phosphodiesterase inhibitors: new opportunities for the treatment of asthma.Thorax, 1991
- Differential modulation of tissue function and therapeutic potential of selective inhibitors of cyclic nucleotide phosphodiesterase isoenzymesTrends in Pharmacological Sciences, 1991
- Effect of isozyme selective phosphodiesterase inhibitors on bovine tracheal smooth muscle toneEuropean Journal of Pharmacology, 1990
- Cyclic nucleotide phosphodiesterase (PDE) isoenzymes in bovine tracheal smooth muscle, their inhibition and the ability of isoenzyme inhibitors to relax precontracted preparationsEuropean Journal of Pharmacology, 1990
- Modulation of carbachol-induced inositol phosphate formation in bovine tracheal smooth muscle by cyclic AMP phosphodiesterase inhibitorsBiochemical Pharmacology, 1990
- Regulation of Ca2+ -dependent K+ -channel activity in tracheal myocytes by phosphorylationNature, 1989
- Differential pharmacologic sensitivity of cyclic nucleotide phosphodiesterase isozymes isolated from cardiac muscle, arterial and airway smooth muscleEuropean Journal of Pharmacology, 1988
- Pharmacological studies with SK&F 94120, a novel positive inotropic agent with vasodilator activityJournal of Pharmacy and Pharmacology, 1986
- The Pharmacology of a β2-Selective Adrenoceptor Antagonist (ICI 118,551)Journal of Cardiovascular Pharmacology, 1983
- Role of intracellular Ca2+ sequestration in β-adrenergic relaxation of a smooth muscleNature, 1979